L-Dihydroorotic acid
-
L-Dihydroorotic acid
structure -
-
CAS No:
5988-19-2
-
Formula:
C5H6N2O4
-
Chemical Name:
L-Dihydroorotic acid
-
Synonyms:
4-Pyrimidinecarboxylic acid,hexahydro-2,6-dioxo-,(4S)-;Hydroorotic acid,L-;4-Pyrimidinecarboxylic acid,hexahydro-2,6-dioxo-,(S)-;(4S)-Hexahydro-2,6-dioxo-4-pyrimidinecarboxylic acid;L-Dihydroorotate;L-Dihydroorotic acid;L-5,6-Dihydroorotic acid;(4S)-2,6-Dioxo-1,3-diazinane-4-carboxylic acid;(S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid
- Categories:
-
CAS No:
Description
L-Dihydroorotic acid can reversibly hydrolyze to yield the acyclic L-ureidosuccinic acid by dihydrowhey enzyme[1].
Solid
(S)-dihydroorotic acid is the (S)-enantiomer of dihydroorotic acid that is an intermediate in the metabolism of pyridine. It has a role as a Saccharomyces cerevisiae metabolite, a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a conjugate acid of a (S)-dihydroorotate. It is an enantiomer of a (R)-dihydroorotic acid.
Characteristics
95.5
-1.5
White to off-white Powder
1.9±0.1 g/cm3
267-268 °C (decomp)
270.7±32.9 °C
1.714
soluble in water (partly), and dimethyl formamide.
Store at 0-5°C
145.44 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|125.5 Ų [M-H]-
Safety Information
NONH for all modes of transport
3
36/37/38
26-36
Xi
P261-P305 + P351 + P338
H315-H319-H335
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 129 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
L-Dihydroorotic acid Use and Manufacturing
Used as a freshener, flavoring agent, can be used in households, restaurants, etc.As a food additive: Breast milk contains uridine acid (UMP), cytidine acid (CMP), adenylic acid (AMP), guanylic acid (GMP), inosinic acid (IMP) and other nucleotides to improve Infant’s immune regulation and memory play a role.As raw materials for medicine: Nucleotides are used as medicine to inhibit inflammation of the urethra.
Computed Properties
Molecular Weight:158.11
XLogP3:-1.5
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:1
Exact Mass:158.03275668
Monoisotopic Mass:158.03275668
Topological Polar Surface Area:95.5
Heavy Atom Count:11
Complexity:225
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Giving mice 20.0ml and 10.0ml/kg body weight of 28-flavor kidney-tonifying oral liquid (equivalent to 11.2g and 5.6g/kg of crude drug, respectively) can significantly improve the sexual function of male mice and increase the number of vaginal plugs in female mice in the same cage. 28-flavor kidney-tonifying capsule (5.4g/kg of crude drug) also has a similar effect. High-dose oral liquid can increase the activity of SOD in the whole blood of mice, indicating that this product has a certain effect on delaying aging. 28-flavor kidney-tonifying capsule also has the same effect, but the effect of oral liquid (raw drug) 11.2g/kg of body weight is better than capsule (5.4g/kg of body weight). Acute toxicity test: 1g of 28-flavor kidney-tonifying oral liquid was given to mice, and the maximum daily tolerance was greater than 90ml/kg (equivalent to 50.4g of crude drug), which is 225 times the daily dose to be used clinically; ip administration, the maximum daily tolerance was greater than 40ml/kg (equivalent to 22.4g of crude drug), indicating that this product has little toxicity. Long-term toxicity test: rats were gavaged with twice-concentrated 28-flavor kidney-tonifying oral liquid, with a maximum daily dose of 15 ml/kg, equivalent to 16.8 g/kg body weight of crude drug, which is 75 times the proposed clinical daily dose. The drug was administered for 12 consecutive weeks. No toxic or adverse reactions were observed in the animal's appearance, body weight, organ coefficient, blood picture, blood biochemistry, and pathological examination of 12 major organ tissues, and no deaths occurred. The proposed clinical dose of this product is safe.
Recommended Suppliers of L-Dihydroorotic acid
-
InquiryCAS No.: 5988-19-2Grade: Pharmaceutical GradeContent: 99%
-
CN
3 YRS
Business licensedTrader Supplier of Apigenin,PQQ,NMNHInquiryUnit Price: $100 /Unit EXWCAS No.: 5988-19-2Grade: Industrial GradeContent: 98% -
CN
2 YRS
Business licensed Certified factoryManufactory Supplier of semaglutide intermediates,tirzepatide intermediate,degludec intermediate,insulin detemir,retatrutide intermediate
Learn More Other Chemicals
-
3,5-DIBROMO-2-[[[(3,5-DINITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
535965-38-9
-
3,5-DIBROMO-2-[[[[(2-CHLOROPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532386-89-3
-
3,5-DIBROMO-2-[[[(4-METHYL-3-NITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532943-48-9
-
3,5-DIBROMO-2-[[[[3-(2-FURANYL)-1-OXO-2-PROPENYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
586392-09-8
-
3,5-DIBROMO-2-[[[[(2-METHYLPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
531548-30-8
-
2-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid Formula
333340-54-8
-
3,5-DIBROMO-2-[[[[3-(PHENOXYMETHYL)BENZOYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
586393-79-5
-
3,5-DIBROMO-2-[[[(4-CHLOROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
531530-32-2
-
What is 2-Cyclopentyl-3-(2,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-oxo-4-isoquinolinecarboxylic acid
400073-92-9
-
What is 9-Octadecenoic acid (9Z)-, compd. with N,N-dimethylcyclohexanamine (1:1)
65122-23-8